Details of the Drug

General Information of Drug (ID: DMTAOPC)

Drug Name

SAR442720

Synonyms

RMC-4630

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Protein-tyrosine phosphatase SHP-2 (PTPN11)	TT7WUAV	PTN11_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04418661) Safety Study of SAR442720 in Combination With Pembrolizumab in Patients With Advanced Malignancies. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Revolution Medicines.